Webinar: State Tools to Lower Medicaid Prescription Drug Costs – Exploring Payment Methodologies for Retail and Physician-Administered Drugs
Friday, March 29, 2019
2-3 p.m. (EST)
What payment models are the best options to allow savings? How do state Medicaid programs know if what they pay pharmacies for retail drugs and providers for physician-administered drugs is appropriate?
As states struggle with increasing prescription drug costs, they are testing various alternative payment models (APMs). Colorado is exploring a first-in-nation payment methodology for how it reimburses providers for physician-administered drugs (PADs). Colorado surveyed providers across a range of practice sites to better understand how much providers are actually paying for drugs. This survey data would inform an average acquisition cost-based payment methodology for PADs with the potential for $3.4 to $12 million in savings in the first year if implemented.
Additionally, researchers at the Johns Hopkins Bloomberg School of Public Health are studying the National Average Drug Acquisition Cost (NADAC) as a payment methodology for retail pharmacies. They are examining the effectiveness of NADAC as a tool for states and whether the use of NADAC has led to cost savings.
The webinar moderator is National Academy for State Health Policy Executive Director Trish Riley. Speakers are:
- Kevin Martin, BS, Fee for Service Rates Manager, Colorado Department of Health Care Policy and Financing
- Joseph Levy, PhD, Assistant Scientist, Johns Hopkins Bloomberg School of Public Health

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































